In a previous work, we showed that R-115, an oHSV fully retargeted to human HER2 and armed with mIL12, is able to specifically infect HER2 positive glioblastoma cells and to induce a potent and long-lasting immune response against tumor cells [39]. This evidence concerns the gene ERBB2 and neoplasm.